Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
NPJ Systems Biology and Applications|February 8, 2022
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapyMarisol Salgado-Albarrán, Julian Späth, Rodrigo González-Barrios, et al.
Assay and Drug Development Technologies|November 9, 2020
Individuating Possibly Repurposable Drugs and Drug Targets for COVID-19 Treatment Through Hypothesis-Driven Systems Medicine Using CoVexJulian Matschinske, Marisol Salgado-Albarrán, Sepideh Sadegh, et al.
Frontiers in Genetics|April 28, 2022
Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in CancerAylin Del Moral-Morales, Marisol Salgado-Albarrán, Elizabeth Ortiz-Gutiérrez, et al.
Frontiers in Oncology|November 12, 2019
The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic PerspectiveItzel Alejandra Hernández-Romero, Lissania Guerra-Calderas, Marisol Salgado-Albarrán, et al.
Cells|July 6, 2023
CTCF and Its Multi-Partner Network for Chromatin RegulationAylin Del Moral-Morales, Marisol Salgado-Albarrán, Yesennia Sánchez-Pérez, et al.
Nature Computational Science|January 13, 2024
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategiesGihanna Galindez, Julian Matschinske, Tim Daniel Rose, et al.
NPJ Systems Biology and Applications|May 25, 2021
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infectionMarisol Salgado-Albarrán, Erick I Navarro-Delgado, Aylin Del Moral-Morales, et al.
Microorganisms|March 6, 2021
The Transcriptional Regulatory Network of Corynebacterium pseudotuberculosisDoglas Parise, Mariana Teixeira Dornelles Parise, Anne Cybelle Pinto Gomide, et al.
Nature Communications|November 26, 2021
Network medicine for disease module identification and drug repurposing with the NeDRex platformSepideh Sadegh, James Skelton, Elisa Anastasi, et al.
Oncogenesis|August 14, 2019
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancerMarisol Salgado-Albarrán, Rodrigo González-Barrios, Lissania Guerra-Calderas, et al.
Pageof 2